Key steps leading to such accumulation identified; could inform new therapeutic approaches
How do toxic proteins accumulate in Alzheimer’s and other diseases? (Links to an external site)

Key steps leading to such accumulation identified; could inform new therapeutic approaches
Brain areas marked by distinct activity patterns very early, marsupial study shows
Recognizes excellence in cancer care, prevention, research, training, outreach
This episode of ‘Show Me the Science’ focuses on approval of a drug that attacks a key protein that contributes to dementia from Alzheimer’s disease
NIH-supported study lays groundwork for Alzheimer’s clinical trials involving people with intellectual disabilities
Provides baseline to measure progress toward racial equity in care for Alzheimer’s disease
Novel marker found in cerebrospinal fluid also could speed development of Alzheimer’s drugs
Proof-of-concept device could also monitor for flu, RSV, other respiratory viruses
Grant will support research on brain plasticity
This episode of ‘Show Me the Science’ focuses on research into how psychedelic drugs affect the brain and how such effects might help treat anxiety, depression and addiction
Accurate diagnosis is a crucial step toward appropriate treatment
Gut microbes of people with pre-symptomatic Alzheimer’s differ from those of healthy people
As children age, such brain activity becomes similar to how the brains of peers process such cues
Scientists, engineers receive small-business development grant
Award will help advance neuroscience technologies aimed at improving cognitive wellness
Up to $4 million in funding available to pursue ‘investigational new drug’ status
Targeting opioid receptor pathway could treat pain without addiction, hallucinations
Alzheimer’s proteins rise sharply in response to stress in female mice
Washington University neurologist led international trials of the drug, tofersen
More research needed to determine if sleep medications prevent, delay Alzheimer’s